NG-nitro-L-arginine
CAT:
804-HY-12115
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

NG-nitro-L-arginine
- CAS Number: 2149-70-4
- UNSPSC Description: NG-nitro-L-arginine (Nω-nitro-L-arginine) is a NO Synthase inhibitor, with Kis of 0.61 μM (nNOS), 4.28 μM (iNOS), 0.72 μM (eNOS) respectively. NG-nitro-L-arginine inhibits endothelium-derived relaxing factor (EDRF) formation and release. NG-nitro-L-arginine inhibits portal-systemic shunting in portal-hypertensive rats, and increases blood pressure[1][2][3][4].
- Target Antigen: NO Synthase
- Type: Reference compound
- Related Pathways: Immunology/Inflammation
- Field of Research: Cardiovascular Disease
- Assay Protocol: https://www.medchemexpress.com/ng-nitro-l-arginine.html
- Purity: 97.0
- Solubility: DMSO : < 1 mg/mL (ultrasonic)|H2O : 3.33 mg/mL (ultrasonic;adjust pH to 2 with HCl)
- Smiles: N[C@@H](CCCNC(N[N+]([O-])=O)=N)C(O)=O
- Molecular Weight: 219.20
- References & Citations: [1]Seo J, et al. Structure-based design and synthesis of N(omega)-nitro-L-arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water. J Med Chem. 2007 May 3;50(9):2089-99. |[2]Ishii K, et al. N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol. 1990 Feb 6;176(2):219-23. |[3]Lee FY, et al. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology. 1993 Nov;105(5):1464-70.|[4]Molnár M, Hertelendy F. N omega-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol. 1992 May;166(5):1560-7.
- Shipping Conditions: Room Temperature
- Storage Conditions: Store at room temperature 3 years
- Clinical Information: No Development Reported